Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Mader

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Oncology|March 1, 1995
New mucin-like cancer-associated antigens (CA M 26, CA M 29 and CA 549) and a new proliferation marker (TPS) in patients with primary or advanced breast cancerG J Locker, R M Mader, J Braun, et al.
British Journal of Clinical Pharmacology|March 1, 1994
Pharmacokinetics of rac-leucovorin vs [S]-leucovorin in patients with advanced gastrointestinal cancerR M Mader, G G Steger, B Rizovski, et al.
European Journal of Cancer Care|July 19, 2008
Serum levels of tumour necrosis factor-alpha and interleukin-6 and their correlation with body mass index, weight loss, appetite and survival rate--preliminary data of Viennese outpatients with metastatic cancer during palliative chemotherapyM Grim-Stieger, M Keilani, R M Mader, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1994
Double modulation of 5-fluorouracil by high-dose leucovorin and interferon alpha 2b in advanced colorectal cancer: a phase I and a phase II study of weekly administrationG G Steger, R M Mader, M P Djavanmard, et al.
British Journal of Cancer|March 6, 2003
Penetration of capecitabine and its metabolites into malignant and healthy tissues of patients with advanced breast cancerR M Mader, C Schrolnberger, B Rizovski, et al.
Biochemical Pharmacology|January 7, 1998
Transcription and activity of 5-fluorouracil converting enzymes in fluoropyrimidine resistance in colon cancer in vitroR M Mader, A E Sieder, J Braun, et al.
Cancer Research|July 29, 1998
Interstitial methotrexate kinetics in primary breast cancer lesionsM Müller, M Brunner, R Schmid, et al.
The Journal of Laboratory and Clinical Medicine|June 1, 2001
Reverse transcriptase template switching during reverse transcriptase-polymerase chain reaction: artificial generation of deletions in ribonucleotide reductase mRNAR M Mader, W M Schmidt, R Sedivy, et al.
Cancer|October 12, 2001
Penetration of dacarbazine and its active metabolite 5-aminoimidazole-4-carboxamide into cutaneous metastases of human malignant melanomaC Joukhadar, N Klein, R M Mader, et al.
British Journal of Cancer|October 31, 2013
Fulvestrant induces resistance by modulating GPER and CDK6 expression: implication of methyltransferases, deacetylases and the hSWI/SNF chromatin remodelling complexB Giessrigl, W M Schmidt, M Kalipciyan, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Oncology|March 1, 1995
New mucin-like cancer-associated antigens (CA M 26, CA M 29 and CA 549) and a new proliferation marker (TPS) in patients with primary or advanced breast cancerG J Locker, R M Mader, J Braun, et al.
British Journal of Clinical Pharmacology|March 1, 1994
Pharmacokinetics of rac-leucovorin vs [S]-leucovorin in patients with advanced gastrointestinal cancerR M Mader, G G Steger, B Rizovski, et al.
European Journal of Cancer Care|July 19, 2008
Serum levels of tumour necrosis factor-alpha and interleukin-6 and their correlation with body mass index, weight loss, appetite and survival rate--preliminary data of Viennese outpatients with metastatic cancer during palliative chemotherapyM Grim-Stieger, M Keilani, R M Mader, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1994
Double modulation of 5-fluorouracil by high-dose leucovorin and interferon alpha 2b in advanced colorectal cancer: a phase I and a phase II study of weekly administrationG G Steger, R M Mader, M P Djavanmard, et al.
British Journal of Cancer|March 6, 2003
Penetration of capecitabine and its metabolites into malignant and healthy tissues of patients with advanced breast cancerR M Mader, C Schrolnberger, B Rizovski, et al.
Biochemical Pharmacology|January 7, 1998
Transcription and activity of 5-fluorouracil converting enzymes in fluoropyrimidine resistance in colon cancer in vitroR M Mader, A E Sieder, J Braun, et al.
Cancer Research|July 29, 1998
Interstitial methotrexate kinetics in primary breast cancer lesionsM Müller, M Brunner, R Schmid, et al.
The Journal of Laboratory and Clinical Medicine|June 1, 2001
Reverse transcriptase template switching during reverse transcriptase-polymerase chain reaction: artificial generation of deletions in ribonucleotide reductase mRNAR M Mader, W M Schmidt, R Sedivy, et al.
Cancer|October 12, 2001
Penetration of dacarbazine and its active metabolite 5-aminoimidazole-4-carboxamide into cutaneous metastases of human malignant melanomaC Joukhadar, N Klein, R M Mader, et al.
British Journal of Cancer|October 31, 2013
Fulvestrant induces resistance by modulating GPER and CDK6 expression: implication of methyltransferases, deacetylases and the hSWI/SNF chromatin remodelling complexB Giessrigl, W M Schmidt, M Kalipciyan, et al.
Pageof 5